Cargando…

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality

Lin et al. recently did a network meta-analysis based on cardiovascular (CV) outcome trials (CVOTs) of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and those of glucagon-like peptide-1 receptor agonists (GLP1RAs). Due to the absence of CVOTs directly comparing SGLT2is with GLP1RAs, Lin et al....

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Mei, Wei, Xu-Bin, Wei, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688798/ https://www.ncbi.nlm.nih.gov/pubmed/34950720 http://dx.doi.org/10.3389/fcvm.2021.791311

Ejemplares similares

Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality
por: Du, Lixin, et al.
Publicado: (2022)

Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is
por: Du, Lixin, et al.
Publicado: (2022)

Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status
por: Du, Lixin, et al.
Publicado: (2022)

GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression
por: Qiu, Mei, et al.
Publicado: (2020)

The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia
por: Wu, Huanyu, et al.
Publicado: (2022)

The Association of Dietary Vitamin Intake Time Across a Day With Cardiovascular Disease and All-Cause Mortality
por: Gu, Wenbo, et al.
Publicado: (2022)

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy
por: Zeng, Rui-Xiang, et al.
Publicado: (2022)

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
por: Guan, Lihua, et al.
Publicado: (2023)

Commentary: Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Association of Total Bilirubin With All-Cause and Cardiovascular Mortality in the General Population
por: Chen, Ziwei, et al.
Publicado: (2021)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

The association of central and extremity circumference with all-cause mortality and cardiovascular mortality: a cohort study
por: Liu, Jiajun, et al.
Publicado: (2023)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease
por: Kim, Moon-Hyun, et al.
Publicado: (2022)

A U-Shaped Relationship Between Selenium Concentrations and All-Cause or Cardiovascular Mortality in Patients With Hypertension
por: Tan, Qiu-hong, et al.
Publicado: (2021)

Association Between Asthma and All-Cause Mortality and Cardiovascular Disease Morbidity and Mortality: A Meta-Analysis of Cohort Studies
por: Zhang, Bin, et al.
Publicado: (2022)

Estimated pulse wave velocity is associated with all-cause mortality and cardiovascular mortality among adults with diabetes
por: Wu, Li-Da, et al.
Publicado: (2023)

Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study
por: Dzaye, Omar, et al.
Publicado: (2022)

Association of nighttime physical activity with all-cause and cardiovascular mortality: Results from the NHANES
por: Yi, Jiayi, et al.
Publicado: (2022)

Mean arterial pressure trajectory with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study
por: Song, Zongshuang, et al.
Publicado: (2023)

Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease
por: He, Lu, et al.
Publicado: (2022)

Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension
por: Zhao, Songfeng, et al.
Publicado: (2023)

Associations Between Healthy Lifestyle Trajectories and the Incidence of Cardiovascular Disease With All-Cause Mortality: A Large, Prospective, Chinese Cohort Study
por: Ding, Xiong, et al.
Publicado: (2021)

Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
por: Wang, Le, et al.
Publicado: (2021)

Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2021)

The Core Role of Neutrophil–Lymphocyte Ratio to Predict All-Cause and Cardiovascular Mortality: A Research of the 2005–2014 National Health and Nutrition Examination Survey
por: Gu, Linguo, et al.
Publicado: (2022)

Association between serum Klotho concentration and all-cause and cardiovascular mortality among American individuals with hypertension
por: Yan, Yuqin, et al.
Publicado: (2022)

Association of the Composite dietary antioxidant index with all-cause and cardiovascular mortality: A prospective cohort study
por: Wang, Lei, et al.
Publicado: (2022)

The impact of bilateral brachial-ankle pulse wave velocity difference on cardiovascular disease and all-cause mortality
por: Zheng, Mengyi, et al.
Publicado: (2023)

Serum Uric Acid Revealed a U-Shaped Relationship With All-Cause Mortality and Cardiovascular Mortality in High Atherosclerosis Risk Patients: The ASSURE Study
por: Cang, Yan, et al.
Publicado: (2021)

Serum C-peptide level and the risk of cardiovascular diseases mortality and all-cause mortality: a meta-analysis and systematic review
por: Ahmadirad, Hamid, et al.
Publicado: (2023)

Geriatric nutrition risk index in the prediction of all-cause and cardiovascular mortality in elderly hypertensive population: NHANES 1999–2016
por: Huo, Xuan, et al.
Publicado: (2023)

Association of body fat distribution with all-cause and cardiovascular mortality in US adults: a secondary analysis using NHANES
por: Li, Fuhai, et al.
Publicado: (2023)

Association of Metabolic Syndrome With Long-Term Cardiovascular Risks and All-Cause Mortality in Elderly Patients With Obstructive Sleep Apnea
por: Liu, Lin, et al.
Publicado: (2022)

Associations Between Adult Triceps Skinfold Thickness and All-Cause, Cardiovascular and Cerebrovascular Mortality in NHANES 1999–2010: A Retrospective National Study
por: Li, Weiya, et al.
Publicado: (2022)

A Non-Linear Association of Triglyceride Glycemic Index With Cardiovascular and All-Cause Mortality Among Patients With Hypertension
por: Zhou, Dan, et al.
Publicado: (2022)

Association Between Pulse Pressure With All-Cause and Cardiac Mortality in Acute Coronary Syndrome: An Observational Cohort Study
por: Wang, Man, et al.
Publicado: (2022)

Association Between Hemoglobin Glycation Index and Risk of Cardiovascular Disease and All Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis
por: Wu, Jian-di, et al.
Publicado: (2021)

Sex Differences in Physical Activity and Its Association With Cardiac Death and All-Cause Mortality in Patients With Implantable Cardioverter-Defibrillators
por: Li, Xiaoyao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_epvgsv3v5n2qeaemv9chnbr6l9